RecruitingNCT03897374
Strategic Targeting for Optimal Prevention of Cancer
Sponsor
ClinLogic LLC
Enrollment
120,000 participants
Start Date
Mar 26, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which may lead to early detection and treatment of the condition.
Eligibility
Min Age: 65 Years
Inclusion Criteria5
- individuals, ages 65 years or older;
- must have met medical necessity for hereditary cancer genomic testing and allowed the physician to test based on medical necessity;
- hereditary cancer diagnostic test was ordered by a physician related to individual subject care considerations.
- study subject has or had cancer
- study subject has at least one family member with cirrent or past cancer
Exclusion Criteria3
- Study subjects will be excluded from the study if any of the following criteria apply: • study subject is currently hospitalized or incarcerated;
- study subject is unable to provide an accurate history due to mental incapacity
- study subject is currently abusing illicit and/or prescription drugs;
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTGenetic Testing
Buccal swab
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03897374
Related Trials
Avera Cancer Sequencing and Analytics Protocol (ASAP)
NCT051420336 locations
Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
NCT072202391 location
Caris Biorepository Research Protocol
NCT0149939438 locations
Integrating Telehealth to Advance Lung Cancer Screening
NCT066385541 location
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
NCT068922751 location